Published in J Clin Endocrinol Metab on April 01, 1983
Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet (1989) 2.03
Autoimmunity in Graves' ophthalmopathy: a review. J R Soc Med (1989) 1.08
Are antithyroid drugs immunosuppressive? Br Med J (Clin Res Ed) (1984) 0.89
Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms. J Clin Invest (1988) 0.88
Graves' ophthalmopathy: a review of immunogenetics. Curr Genomics (2011) 0.84
beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. Int J Mol Med (2007) 0.82
The new perspectives on genetic studies of type 2 diabetes and thyroid diseases. Curr Genomics (2013) 0.75
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int (2006) 3.20
Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia (1992) 2.72
Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology (1993) 2.29
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int (2006) 2.22
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia (1983) 2.18
Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost (1994) 2.09
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Int J Legal Med (2006) 2.00
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab (2014) 1.99
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab (1997) 1.78
Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest (1995) 1.73
Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes (2009) 1.65
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab (2014) 1.51
Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev (2008) 1.50
Paternity Testing Commission of the International Society of Forensic Genetics. Recommendations on genetic investigations in paternity cases. Int J Legal Med (2003) 1.46
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol (2003) 1.44
Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol (1980) 1.41
Hemodynamic responses to noxious stimuli in brain-dead organ donors. Intensive Care Med (1992) 1.41
[Lispro-insulin analogs in therapy of diabetes]. Wien Klin Wochenschr (1997) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[The HL-A-system in paternity testing (author's transl)]. Z Rechtsmed (1974) 1.39
[What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study]. Schweiz Med Wochenschr (1990) 1.39
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med (1982) 1.38
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab (1997) 1.31
HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme. Biochem Biophys Res Commun (1990) 1.29
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
DNA Commission of the International Society for Forensic Genetics (ISFG): recommendations regarding the role of forensic genetics for disaster victim identification (DVI). Forensic Sci Int Genet (2006) 1.28
Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia (1988) 1.23
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
HLA-DR and Hashimoto's thyroiditis. Tissue Antigens (1980) 1.20
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab (1983) 1.14
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med (1995) 1.14
An epidemiological study of high school ice hockey injuries. Childs Nerv Syst (1987) 1.14
Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion (1996) 1.13
Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol (1998) 1.12
DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet (2012) 1.11
Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism (1984) 1.10
Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms. Vox Sang (1995) 1.10
Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut (1996) 1.10
Nomenclature for factors of the HLA system, 1989. Tissue Antigens (1990) 1.10
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) (2005) 1.08
Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors. Hum Gene Ther (2000) 1.08
Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab (1995) 1.08
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
ISFG: recommendations regarding the use of non-human (animal) DNA in forensic genetic investigations. Forensic Sci Int Genet (2010) 1.06
Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med (1979) 1.06
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg (1997) 1.06
Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials. Haemostasis (1997) 1.05
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion (2001) 1.05
DNA Commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Forensic Sci Int (2001) 1.04
Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia (2011) 1.03
Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab (1984) 1.02
Thrombin generation in morbid obesity: significant reduction after weight loss. J Thromb Haemost (2010) 1.02
HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol (1984) 1.02
Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabete Metab (1986) 1.01
Aspects of the absorption of oral L-thyroxine in normal man. Metabolism (1977) 1.01
Nomenclature for factors of the HLA system, 1990. Hum Immunol (1991) 1.01
Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett (1997) 1.01
Self-administered psychotherapy for depression using a telephone-accessed computer system plus booklets: an open U.S.-U.K. study. J Clin Psychiatry (1998) 1.01
Stimulation of humoral antibody formation by polyanions. V. Relationship between enhancement of sheep red blood cell uptake by the spleen and adjuvant action of dextran sulfate. Eur J Immunol (1971) 1.01
Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer (1990) 1.00
Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) (1989) 1.00
Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol (1996) 1.00
Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab (1994) 0.99
High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang (2011) 0.99
Localization of MPI, PKM2, IDHM, and the alpha subunit of hexosaminidase (HEXA) to the q21 leads to qter region of human chromosome 15. Cytogenet Cell Genet (1978) 0.99
Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung. Ann Rheum Dis (1976) 0.99
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria. Diabet Med (2007) 0.99
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol (2003) 0.98
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol (1992) 0.98
Acute endocrine failure after brain death? Transplantation (1992) 0.98
Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care (1985) 0.98
Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res (2001) 0.97